A retrospective observational study of rituximab treatment in multiple sclerosis patients in Cyprus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A retrospective observational study of rituximab treatment in multiple sclerosis patients in Cyprus

Published:2019-07-30 Issue:7 Volume:131 Page:486-489
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Leonidou Eleni¹,Pantzaris Marios¹²,Kleopa Kleopas A.²³,Loizidou Maria A.⁴,Kyriakides Theodoros²⁵,Christou Yiolanda P.⁶

Affiliation:

1. Neurology Clinic C, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

2. The Cyprus School of Molecular Medicine, Nicosia, Cyprus

3. Neurology Clinic E, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

4. Department of EM/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

5. Neurology Clinic A, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

6. Neurology Clinic D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2019.1649975

Reference18 articles.

1. The Immunopathology of Multiple Sclerosis: An Overview

2. Epidemiology of multiple sclerosis

3. AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS 1

4. Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function

5. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab in secondary progressive multiple sclerosis: a meta‐analysis;Annals of Clinical and Translational Neurology;2024-08-26

2. Efficacy and safety of rituximab in multiple sclerosis: a systematic review and meta-analysis;Acta Neurologica Belgica;2023-07-10

3. Current evidence of rituximab in the treatment of multiple sclerosis;Multiple Sclerosis and Related Disorders;2023-07

4. The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis;CNS Drugs;2022-10-16

5. Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice;International Journal of Nanomedicine;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3